- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07276971
The Safe Early Mobilization on CABG
The Effect of the Safe Early Mobilization Protocol Developed for Patients Underwent Coronary Artery Bypass Graft Surgery on Patient Outcomes
Aim: This study aimed to evaluate the effect of a Safe Early Mobilization Protocol (SEMP) developed for patients undergoing coronary artery bypass graft (CABG) surgery on patient outcomes.
Design: A single-center, parallel-group, randomized controlled trial. Methods: The study was conducted with 60 patients in 2023. The intervention group received a Safe Early Mobilization Protocol including bedside elevation, deep breathing and coughing exercises, sitting upright in bed, sitting on the edge of the bed, standing, ambulation, and sitting in a bedside chair from the day of surgery until the fourth postoperative day. The control group received routine mobilization care. Respiratory parameters, orthostatic hypotension (OH), orthostatic intolerance (OI), mobilization distance, anxiety level, and hospital stay were evaluated.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ankara, Turkey (Türkiye)
- Güven Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Hemodynamic stability, defined as:
Resting heart rate <110/min
Mean arterial pressure between 60-110 mmHg
Oxygen saturation (SpO₂) >88%
Receiving dopamine infusion ≤5 mcg/kg/min at the time of enrollment
No auditory, speech, or visual impairments
No neurological contraindications (e.g., cerebrovascular accident [CVA], ataxia, multiple sclerosis [MS])
No orthopedic contraindications that prevent mobilization (e.g., fractures or sequelae)
Provided informed consent to participate in the study
Age ≥18 years
Able to speak Turkish
Literate patients
Exclusion Criteria:
Requirement for intra-aortic balloon pump (IABP) support
Postoperative cerebrovascular events
High-dose inotropic drug infusion in the early postoperative period:
Dopamine ≥10 mcg/kg/min
Norepinephrine ≥0.5 mcg/kg/min
Concurrent dopamine and norepinephrine infusion
Severe arrhythmias preventing mobilization, including:
Sinus tachycardia ≥120/min
Rapid atrial fibrillation
Ventricular tachycardia
Ventricular fibrillation
Advanced chronic obstructive pulmonary disease (COPD) or bronchiectasis
Diagnosed anxiety disorders
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: SEMP
A safe early mobilization protocol developed by the researchers was applied.
|
This protocol was developed to guide the early postoperative mobilization of patients undergoing coronary artery bypass graft surgery, covering the period from the day of surgery to the fourth postoperative day.
Prior to mobilization, patients are evaluated using a checklist ensuring physical and environmental safety.
On the day of surgery, following extubation by the responsible physician, six stages are applied: bed head elevation, deep breathing exercises, incentive spirometry, passive range of motion (ROM) exercises, sitting upright (90°), and sitting on the edge of the bed.
On postoperative days 1-3, standing at the bedside, ambulation, and sitting on a chair are added.
Target walking distances are 100-150 m on day 1, 200-250 m on day 2, and 300-350 m on day 3. Distances are measured by the researcher using a meter.
The protocol concludes on the 4th postoperative day when the patient can ambulate independently.
|
|
Active Comparator: Control group
The routine protocol used in the hospital was applied.
|
Patients in the control group were informed about the current mobilization practices applied in the clinic before surgery.
The morning after the surgery (the first day after the surgery), the patient is first seated in the bed, and in the second stage, he is made to sit on the edge of the bed with his feet touching the floor and is observed.
In the third stage, the patient stands in an upright position and if there is no dizziness or blackout, the patient is seated on a chair next to the bed.
The duration of sitting in the chair is determined depending on the general condition of the patient (pain, dizziness, blackout, nausea).
On the 2nd and 3rd postoperative day, patients were contacted by nurses and care support staff while they had a chest tube; Then, the patient is mobilized only with his/her relative.
There is no standard practice regarding how long patients should be mobilized during the day.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants With Orthostatic Hypotension
Time Frame: Daily postoperative measurements for up to 3 days.
|
Orthostatic hypotension defined as a ≥20 mmHg decrease in systolic BP and/or ≥10 mmHg decrease in diastolic BP.
|
Daily postoperative measurements for up to 3 days.
|
|
Number of Participants With Orthostatic Intolerance
Time Frame: Daily postoperative assessments for up to 3 days.
|
Orthostatic intolerance defined as the presence of dizziness, nausea, weakness, blurred vision, or syncope.considered
as OI.
|
Daily postoperative assessments for up to 3 days.
|
|
Oxygen Saturation Level (%)
Time Frame: Daily postoperative measurements for up to 3 days.
|
Peripheral oxygen saturation (SpO₂) measured using pulse oximetry.
|
Daily postoperative measurements for up to 3 days.
|
|
State Anxiety Scale Score
Time Frame: Postoperative day 1 and postoperative day 4.
|
The State Anxiety Inventory (STAI-S) will be used (score range: 20-80; higher scores indicate worse anxiety).
|
Postoperative day 1 and postoperative day 4.
|
|
Six-Minute Walk Test Distance (Meters)
Time Frame: Postoperative day 4.
|
Distance walked during the Six-Minute Walk Test (0-∞ meters; higher distance indicates better functional capacity).
|
Postoperative day 4.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Length of Hospital Stay (Days)
Time Frame: From postoperative day 0 until hospital discharge (up to 30 days).
|
Total duration of postoperative hospitalization, including ICU and ward stay.
|
From postoperative day 0 until hospital discharge (up to 30 days).
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 36970
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Bypass Graft
-
Queen Mary University of LondonRecruitingCoronary Artery Bypass | CABG | Valve Surgery | Coronary Artery Bypass Graft | Cardiovascular | Valve Replacement | Coronary Artery Bypass Graft Surgery (CABG)United Kingdom
-
University of EdinburghNHS LothianRecruitingCoronary Artery Bypass | Coronary Artery Bypass Graft | Graft Failure | Coronary Artery Bypass Graft Surgery (CABG)United Kingdom
-
Riphah International UniversityCompleted
-
Loma Linda UniversityEdwards LifesciencesCompletedCoronary Artery Bypass GraftUnited States
-
Montreal Heart InstituteCompletedCoronary Artery Bypass GraftCanada
-
China National Center for Cardiovascular DiseasesRecruitingCoronary Artery Bypass Graft (CABG)China
-
Yuzuncu Yıl UniversityAtaturk UniversityRecruitingCoronary Artery Bypass Graft SurgeryTurkey
-
Cairo UniversityCompletedCoronary Artery Bypass Graft CABGEgypt
-
University of Sao PauloFundação ZerbiniCompletedCoronary Artery Bypass Graft SurgeryBrazil
-
Riphah International UniversityEnrolling by invitationCoronary Artery Bypass Graft CABGPakistan
Clinical Trials on The safe early mobilization protocol
-
Robert Wood Johnson Barnabas HealthBrielle Orthopedics; Universtiy Orthopedics AssociatesRecruitingDistal Radius FractureUnited States
-
Uludag UniversityEnrolling by invitationGastrointestinal DiseasesTurkey
-
Universidade Federal de Santa MariaCompletedQuality of Life | Muscle Weakness | ICU Length of Stay | Weaning Acceleration | Muscle Thickness of the Quadriceps FemorisBrazil
-
University of PecsNational Institute of Mental, Neurological and Neurosurgery; Borsod-Abaúj-Zemplén...RecruitingSubarachnoid Hemorrhage, Aneurysmal | Early Ambulation | Standard of CareHungary
-
University of Sao PauloNot yet recruitingRehabilitation | Physiotherapy | Early Mobilization
-
Southeast University, ChinaUnknown
-
Hospital de Clinicas de Porto AlegreFederal University of Rio Grande do SulRecruitingDecompensated Heart FailureBrazil
-
Centre for Interdisciplinary Research in Rehabilitation...Jewish General HospitalNot yet recruiting
-
University of HailRecruitingFlexor Tendon RuptureSaudi Arabia
-
Washington University School of MedicineBarnes-Jewish HospitalCompletedRotator Cuff TearUnited States